BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 316 participants.
Also called NCT06059638
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 316 participants
- Sponsor
- Registry
-
NCT06059638
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, China, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06059638. Randomized; triple masking; primary purpose treatment. Start 2023-12-27 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Acronym
- BACKBEAT
- Condition
- Hypertension
- Condition
- Hypertension, Systolic
- Condition
- Hypertension, Essential
- Intervention (Device)
- Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated
- Intervention (Device)
- Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated
- Lead sponsor
- Orchestra BioMed, Inc
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct06059638- Content hash
51c9f128a918b70d1eca04e1579d3b742df675acfcb0c71cdd40d768e05b1354